# FDA Inspection 1222114 - Haupt Pharma Muenster GmbH - November 24, 2021

Source: https://www.keypedia.com/records/fda_inspections/haupt-pharma-muenster-gmbh/d70a44f7-7be5-4957-b741-002da32c37c3
Source feed: FDA_Inspections

> FDA Inspection 1222114 for Haupt Pharma Muenster GmbH on November 24, 2021. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1222114
- Company Name: Haupt Pharma Muenster GmbH
- Inspection Date: 2021-11-24
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1059379 - 2018-07-06](https://www.keypedia.com/records/fda_inspections/haupt-pharma-muenster-gmbh/4cba233f-342f-4540-b7e3-f0dff689c21f)
- [FDA Inspection 875643 - 2014-03-21](https://www.keypedia.com/records/fda_inspections/haupt-pharma-muenster-gmbh/e31e18fb-6dff-4ec1-beb5-92b22395d2bc)
- [FDA Inspection 775211 - 2012-03-30](https://www.keypedia.com/records/fda_inspections/haupt-pharma-muenster-gmbh/7c5e51f8-b368-4246-9fee-caf1b19d5e05)

Company: https://www.keypedia.com/companies/haupt-pharma-muenster-gmbh/09cdc4cc-6cbc-4904-baa2-d4013dae9741

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c